The Global Health Body Raises Warning Over Severe Scarcity of Weight-Loss Injections

Under a tenth of individuals who could benefit from weight-loss injections such as Wegovy can access them, caution the World Health Organization as it releases its initial guidance on the therapies.

With over a billion people worldwide currently classified as obese, it is advocating for broader and more equitable availability to these injectable treatments.

Per projections, in excess of 2,000,000,000 are projected to be living with obesity by 2030 unless action is taken.

"Our latest guidelines affirms that excess weight is a lifelong illness that can be addressed with holistic and lifelong support," said WHO director-general Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and supply-chain constraints are key hurdles to broad availability to the jabs that can aid individuals in losing considerable body mass, explains the agency.

GLP-1 Therapy Shortage

Even in the current best projected scenario, the manufacturing of such drugs might only reach around 100 million people – under 10% of eligible patients, per the health organization.

The guideline calls on governments and firms to expand availability, through approaches such as patent sharing.

The intellectual property rights on semaglutide – the primary ingredient of the drug Wegovy – is set to lapse in multiple countries in 2026.

How Obesity Drugs Function

GLP-1 drugs replicate a biological compound to slow digestion, curb appetite and boost satiety so people consume fewer calories.

People commonly begin shedding pounds within a few weeks of starting on the regular doses.

Research points to people may see weight return within a year of discontinuing the treatment, as their normal food cravings resume.

To be overweight or obese increases your chance for contracting medical conditions, including type 2 diabetes, cardiovascular issues, brain attack, and certain cancers.

Obesity impacts individuals in all nations and was associated with over three and a half million fatalities worldwide in 2024, as per the health agency.

Joshua Osborn
Joshua Osborn

Elena is a seasoned interior designer and home renovation expert based in Haarlem, with over 15 years of experience.